ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
67.10
-0.02 (-0.03%)
Aug 11, 2026, 4:00 PM EDT - Market closed
SBIO Holdings Information
SBIO is an equity ETF with a total of 107 individual holdings. The top holdings are Crinetics Pharmaceuticals stock at 4.48%, Apogee Therapeutics at 4.22%, CG Oncology at 3.35%, Xenon Pharmaceuticals at 3.09%, and Oruka Therapeutics at 3.01%.
Total Holdings
107
Top 10 Percentage
31.53%
Asset Class
Equity
ETF Category
Health
Assets
201.62M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.48% |
| 2 | APGE | Apogee Therapeutics, Inc. | 4.22% |
| 3 | CGON | CG Oncology, Inc. | 3.35% |
| 4 | XENE | Xenon Pharmaceuticals Inc. | 3.09% |
| 5 | ORKA | Oruka Therapeutics, Inc. | 3.01% |
| 6 | DNTH | Dianthus Therapeutics, Inc. | 3.01% |
| 7 | TVTX | Travere Therapeutics, Inc. | 2.88% |
| 8 | DFTX | Definium Therapeutics, Inc. | 2.55% |
| 9 | ACAD | ACADIA Pharmaceuticals Inc. | 2.53% |
| 10 | MANE | Veradermics, Incorporated | 2.41% |
| 11 | EWTX | Edgewise Therapeutics, Inc. | 2.37% |
| 12 | DYN | Dyne Therapeutics, Inc. | 2.20% |
| 13 | RLAY | Relay Therapeutics, Inc. | 2.18% |
| 14 | DNLI | Denali Therapeutics Inc. | 1.99% |
| 15 | GPCR | Structure Therapeutics Inc. | 1.91% |
| 16 | NAMS | NewAmsterdam Pharma Company N.V. | 1.65% |
| 17 | CLDX | Celldex Therapeutics, Inc. | 1.65% |
| 18 | IDYA | IDEAYA Biosciences, Inc. | 1.65% |
| 19 | MBX | MBX Biosciences, Inc. | 1.63% |
| 20 | IRON | Disc Medicine, Inc. | 1.50% |
| 21 | IMNM | Immunome, Inc. | 1.43% |
| 22 | TARS | Tarsus Pharmaceuticals, Inc. | 1.41% |
| 23 | VRDN | Viridian Therapeutics, Inc. | 1.32% |
| 24 | NKTR | Nektar Therapeutics | 1.31% |
| 25 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.28% |
As of Aug 7, 2026